Marijuana is increasingly utilized to reduce pain in certain pathological conditions such as cancer and multiple sclerosis. It has been found that a particular balance of the chemicals called as cannabinoids effect the various breeds of marijuana to work differently.
Cannabidiol is a type of cannabinoid that reduces inflammation without producing any psychoactive side effects. However, the usage of cannabidiol could lead to the use of tetrahydrocannabinol.
Tetrahydrocannabinol or THC is a type of cannabinoid that acts on the cannabinoid receptors in the brain to create the sensation of being high. This feeling is utilized by recreational drug users but this is an unwanted side effect. As the patients, using marijuana to get rid of pain find themselves unable to work normally.
Tikun Olam (Hebrew for “healing the world”), an Israeli company, is working on to grow a particular breed of plants that will have reduced levels of psychoactive THC while maintaining the cannabidiol. Their work led to Avidekel, a marijuana breed having 15.8% cannabidiol but fewer traces of THC. Clinical trials of the efficiency of this breed has been done in mice but in human beings trials are still in process.
Tikun Olam’s head of development Zack Klein told Reuters: “Sometimes the high is not always what they need. Sometimes it is an unwanted side effect. For some of the people it’s not even pleasant.”